ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $85 | -26.7% | 36,923 | -3.2% | 0.01% | -27.3% |
| Q1 2023 | $116 | -57.5% | 38,160 | -67.4% | 0.01% | -67.6% |
| Q4 2022 | $273 | -99.8% | 117,191 | +23.6% | 0.03% | +41.7% |
| Q3 2022 | $181,000 | +311.4% | 94,800 | +487.5% | 0.02% | +242.9% |
| Q2 2022 | $44,000 | -54.6% | 16,136 | -50.3% | 0.01% | -46.2% |
| Q1 2022 | $97,000 | -90.6% | 32,453 | -89.5% | 0.01% | -92.4% |
| Q1 2021 | $1,032,000 | +1009.7% | 309,839 | +1081.6% | 0.17% | +1040.0% |
| Q4 2020 | $93,000 | – | 26,221 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |